Estée Lauder Companies
EL
$78.95
-0.53%
The Estée Lauder Companies Inc. is a global leader in the prestige beauty market, operating across skin care, makeup, fragrance, and hair care segments. The company is distinguished by its portfolio of iconic, high-margin luxury brands like Estée Lauder, Clinique, and La Mer, and its dominant position in key channels such as travel retail. The current investor narrative is intensely focused on the company's multi-year turnaround plan, which aims to restore growth and profitability after a period of significant challenges, a focus underscored by recent news of the company walking away from merger talks to pursue its independent strategy.…
EL
Estée Lauder Companies
$78.95
Related headlines
Investment Opinion: Should I buy EL Today?
Rating: Hold. The core thesis is that EL presents a high-risk, high-potential-reward turnaround story that is too early to call, requiring concrete evidence of sustained profitability recovery before warranting a Buy rating, despite the attractive valuation discount.
The Hold rating is supported by four specific data points. First, valuation is compelling at a forward PS of ~1.68x, a deep discount to history and peers. Second, revenue growth has tentatively turned positive at 5.8% YoY. Third, free cash flow generation remains strong at $1.14B TTM, providing a financial cushion. Fourth, analyst sentiment implies a 20% upside to revenue-based targets ($97), but this is contingent on successful execution. However, these are counterbalanced by a negative TTM net margin of -7.93%, a high debt-to-equity of 2.44, and a stock price that remains in a firm downtrend.
The two biggest risks that could invalidate a future upgrade are: 1) a return to consistent quarterly net losses, and 2) a deceleration in sequential revenue growth. This Hold would upgrade to a Buy if the company reports two consecutive quarters of expanding operating margins above 10% and reduces its debt-to-equity ratio below 2.0. It would downgrade to a Sell if revenue growth turns negative again or if liquidity concerns emerge (e.g., current ratio falling below 1.0). The stock is currently undervalued relative to its long-term history and brand strength, but fairly valued given its near-term execution risks and financial leverage.
Sign up to view all
EL 12-Month Price Forecast
The AI assessment is Neutral with Medium confidence. EL is a classic 'show me' story where compelling valuation (bull case) clashes with severe fundamental deterioration (bear case). The high free cash flow and iconic brands provide a foundation for recovery, but the negative net margins and elevated debt require proof of a sustained operational fix. The base case of gradual, volatile progress is most likely. The stance would upgrade to Bullish on evidence of two consecutive quarters of double-digit operating margins and a clear path to debt reduction. It would downgrade to Bearish if revenue growth reverses or liquidity metrics deteriorate.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Estée Lauder Companies's 12-month outlook, with a consensus price target around $102.64 and implied upside of +30.0% versus the current price.
Average Target
$102.64
14 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
14
covering this stock
Price Range
$63 - $103
Analyst target range
Analyst coverage is robust with 14 firms providing estimates, and the sentiment leans cautiously optimistic with a mix of Buy, Overweight, and Hold ratings, as evidenced by recent actions from Deutsche Bank (Buy) and Citigroup (upgrade to Buy). The consensus average target price is not explicitly provided in the data, but using the average revenue estimate of $17.30 billion and the current PS ratio of 2.04x implies a market cap target of approximately $35.3 billion, or roughly $97 per share based on 364.8 million diluted shares, suggesting significant potential upside from the current $80.54 price if the company can meet its revenue forecasts. The target range, inferred from revenue estimates, is wide, with a low of $16.94 billion and a high of $17.51 billion; the high end assumes successful execution of the turnaround plan and a recovery in key markets like China and travel retail, while the low end likely prices in further macroeconomic headwinds and execution missteps. The recent pattern of ratings includes an upgrade (Citigroup to Buy) and several reaffirmations, indicating analysts are closely monitoring the turnaround but are not yet universally convinced, resulting in a wide target spread that reflects high uncertainty around the company's near-term prospects.
Bulls vs Bears: EL Investment Factors
The bull and bear cases for Estée Lauder are in a tense standoff, with the bear side currently holding stronger evidence due to the company's concrete financial struggles—negative net margins, high debt, and volatile earnings. The bull case rests on the potential for a successful multi-year turnaround from a deeply oversold valuation, supported by strong brands and cash flow. The single most important tension in the investment debate is the execution risk of the turnaround plan. If management can demonstrably stabilize profitability and deliver consistent quarterly growth, the stock's depressed multiple could expand rapidly. However, if the plan falters or macro headwinds persist, the high debt load and negative margins could lead to further downside, testing the 52-week low of $66.22.
Bullish
- Deeply Undervalued Price-to-Sales Ratio: EL trades at a trailing PS ratio of 2.04x, a significant discount to its historical levels above 4x and the broader industry range of 2.5x-4x. This depressed multiple suggests the market is pricing in a worst-case scenario, leaving substantial room for multiple expansion if the turnaround plan shows progress.
- Strong Free Cash Flow Generation: Despite profitability challenges, the company generated $1.14 billion in TTM free cash flow. This robust cash generation provides the liquidity necessary to fund its turnaround, service its debt, and return capital to shareholders, underpinning financial stability during the transition.
- Revenue Stabilization and Sequential Growth: Q2 2026 revenue of $4.24 billion grew 5.8% YoY, a sharp reversal from the -14.6% decline in the year-ago quarter. Sequential growth from Q1's $3.48 billion also indicates a potential inflection point, though quarterly volatility remains a concern.
- Iconic Brand Portfolio with High Gross Margins: The company's portfolio of luxury brands like La Mer and Clinique supports a robust gross margin of 73.9%. This structural advantage provides a wide moat and significant operating leverage potential if the company can control its selling, general, and administrative expenses more effectively.
Bearish
- Severe Profitability Erosion and Negative Margins: The company's TTM net margin is -7.93%, with a trailing EPS of -$0.04. While Q2 showed a net income of $162 million, it followed a staggering loss of -$546 million in Q4 2025, highlighting extreme earnings volatility and an ongoing struggle to achieve consistent bottom-line results.
- High Financial Leverage and Debt Burden: EL's debt-to-equity ratio stands at a concerning 2.44, indicating significant financial leverage. This high debt load increases interest expense risk and limits financial flexibility, making the company more vulnerable to operational missteps or rising interest rates.
- Persistent Technical Downtrend and High Volatility: The stock is in a pronounced downtrend, trading at just 36% of its 52-week range and down -31.46% YTD versus the SPY. With a beta of 1.25, it is 25% more volatile than the market, exposing investors to amplified downside risk during market corrections.
- Inconsistent Quarterly Execution and High SG&A: Revenue and earnings show high quarterly volatility, as seen in the swing from a $546M loss to a $162M profit. High SG&A expenses (over $2.6B in Q2) continue to pressure operating margins, which were only 6.7% in Q2, indicating the turnaround's cost-saving benefits are not yet fully realized.
EL Technical Analysis
The stock is in a pronounced long-term downtrend, trading near the bottom of its 52-week range. With a 1-year price change of only +1.91% and a current price of $80.54, the stock is positioned at just 36% of its 52-week range (from a low of $66.22 to a high of $121.64), indicating it is deeply oversold and may represent a value opportunity, though it remains a 'falling knife' until a clear reversal is established. Recent momentum shows a significant divergence, with the stock up 19.80% over the last three months but down -11.69% over the past month, suggesting the nascent recovery from the March lows has lost steam and encountered renewed selling pressure, highlighting ongoing volatility and uncertainty. Key technical support is firmly established at the 52-week low of $66.22, while resistance sits at the 52-week high of $121.64; a sustained move above the recent high near $90 would be needed to signal a more durable recovery. The stock's beta of 1.25 indicates it is approximately 25% more volatile than the broader market (SPY), which is critical for risk management, especially given its -31.46% year-to-date underperformance versus the SPY's +6.90% gain.
Beta
1.25
1.25x market volatility
Max Drawdown
-43.8%
Largest decline past year
52-Week Range
$66-$122
Price range past year
Annual Return
-2.3%
Cumulative gain past year
| Period | EL Return | S&P 500 |
|---|---|---|
| 1m | -11.2% | -1.3% |
| 3m | +11.7% | +14.0% |
| 6m | -24.6% | +9.5% |
| 1y | -2.3% | +20.9% |
| ytd | -26.0% | +9.5% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
EL Fundamental Analysis
Revenue growth is showing tentative signs of stabilization but remains inconsistent; the most recent quarterly revenue of $4.24 billion represents a 5.8% year-over-year increase, a significant improvement from the -14.6% decline in the year-ago quarter, yet the sequential trend from Q1's $3.48 billion indicates volatile quarterly performance. The company's profitability is under severe pressure, with a trailing twelve-month net margin of -7.93% and a quarterly net income of $162 million in Q2 2026, which, while positive, follows a staggering net loss of -$546 million in the prior quarter (Q4 2025); the gross margin remains robust at 73.9%, but operating leverage has been elusive due to high fixed costs. The balance sheet and cash flow present a mixed picture: the company carries a high debt-to-equity ratio of 2.44, indicating significant financial leverage, but it generated substantial free cash flow of $1.14 billion over the trailing twelve months and maintains a current ratio of 1.30, suggesting it has the liquidity to navigate its turnaround, though the high debt load remains a key risk.
Quarterly Revenue
$4.2B
2025-12
Revenue YoY Growth
+0.05%
YoY Comparison
Gross Margin
+0.76%
Latest Quarter
Free Cash Flow
$1.1B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is EL Overvalued?
Given the company's inconsistent profitability, with a trailing net income of -$0.04 per share, the primary valuation metric is the Price-to-Sales (PS) ratio. The stock trades at a trailing PS ratio of 2.04x and a forward PS ratio (based on estimated revenue) of approximately 1.68x, with the forward discount implying the market expects only modest revenue growth and continued margin challenges. Compared to the broader Household & Personal Products industry, which often trades at PS ratios between 2.5x and 4x for stable consumer staples, EL's 2.04x multiple represents a discount, reflecting investor skepticism about its growth trajectory and ongoing restructuring costs. Historically, EL's own PS ratio has been significantly higher, frequently above 4x during its growth heyday; trading near 2.04x places it at the low end of its historical range, suggesting the market is pricing in a pessimistic scenario of prolonged stagnation, leaving room for multiple expansion if the turnaround shows concrete progress.
PE
-25.7x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range -533x~438x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
184.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are pronounced. The company's debt-to-equity ratio of 2.44 signifies a heavy leverage burden, with interest expense consuming a significant portion of operating income. Profitability is severely compromised, with a TTM net margin of -7.93% and extreme quarterly volatility, as evidenced by the swing from a -$546 million loss to a $162 million profit. While gross margins are robust at 73.9%, the inability to translate this into consistent net income due to high fixed SG&A costs (over $2.6B last quarter) remains a core operational risk. Revenue, though showing a 5.8% YoY increase in Q2, remains inconsistent on a sequential basis, indicating the recovery is fragile.
Market & Competitive Risks are elevated. The stock trades at a significant discount to its historical and peer valuations (PS of 2.04x), but this discount could persist or widen if the turnaround fails to meet expectations. The company's high beta of 1.25 means it is 25% more volatile than the broader market, amplifying downside during sector rotations away from challenged consumer names. Competitive intensity in prestige beauty remains fierce, and EL's heavy reliance on travel retail (a key part of its 37% EMEA revenue) exposes it to geopolitical tensions and shifts in global travel patterns. The recent news of walking away from merger talks reinforces a 'go-it-alone' strategy, concentrating execution risk entirely on internal management.
Worst-Case Scenario involves a failure of the turnaround plan coupled with a macroeconomic slowdown, particularly in its key Asia-Pacific market. This could trigger a sequence of declining revenues, margin compression, credit rating downgrades, and a liquidity crunch despite current strong cash flow. In this adverse scenario, the stock could re-test its 52-week low of $66.22, representing a potential loss of approximately -18% from the current price of $80.54. A breach of this level could see the stock fall toward the -43.79% max drawdown level observed recently, implying a realistic downside risk in the range of -20% to -30% if sentiment turns decisively negative.
FAQ
The key risks are, in order of severity: 1) Financial Risk: High leverage with a debt-to-equity ratio of 2.44, coupled with inconsistent profitability (TTM net margin -7.93%), could strain liquidity in a downturn. 2) Execution Risk: The multi-year turnaround plan may fail to deliver sustained margin improvement, as seen in volatile quarterly results (e.g., Q4 2025 net loss of -$546M). 3) Market Risk: The stock is 25% more volatile than the market (beta 1.25) and has significantly underperformed the SPY YTD (-31.46%), exposing holders to amplified downside. 4) Competitive/Macro Risk: Slow recovery in key markets like China travel retail or increased competition could stifle revenue growth, currently at a tentative 5.8% YoY.
The 12-month forecast is highly bifurcated, with a base case target range of $85-$100 (55% probability), a bull case of $110-$121 (25% probability), and a bear case of $66-$75 (20% probability). The base case, which is most likely, assumes the company makes gradual, uneven progress on its turnaround, leading to modest revenue growth near analyst estimates of $17.30B and a stabilization in margins. The key assumption behind this forecast is that management avoids major missteps and the macro environment does not worsen. The wide range reflects the high uncertainty and binary nature of the investment thesis at this stage.
EL is undervalued relative to its own historical trading range and the intrinsic value of its brand portfolio, but fairly valued given its near-term fundamental challenges. Historically, EL often traded at a Price-to-Sales (PS) ratio above 4x; today it trades at 2.04x. Compared to the broader Household & Personal Products industry, which often trades between 2.5x and 4x, EL is at a discount. This discount reflects the market's justified skepticism about its ability to return to consistent profitability. The valuation implies the market expects only a slow, uncertain recovery, leaving room for significant upside if execution improves.
EL is a speculative buy, not a core holding. For investors with a high risk tolerance and a 3-5 year horizon, the current price near $80.54 offers an attractive entry point into a world-class brand portfolio at a deep valuation discount (PS 2.04x). The potential upside to analyst-implied targets near $97 is meaningful (~20%). However, it is not a good buy for risk-averse investors due to its severe profitability issues (negative net margin), high debt (D/E 2.44), and persistent stock price downtrend. It is only a good buy under the condition that you believe management's multi-year turnaround plan will succeed.
EL is strictly suitable for long-term investment with a minimum holding period of 3-5 years. This is a turnaround story that will take multiple quarters, if not years, to play out, as evidenced by its multi-year restructuring plan. The stock's high beta (1.25) and recent -43.79% max drawdown make it far too volatile for short-term trading. Furthermore, its negligible dividend yield (0.02%) offers no income cushion for short-term holders. Long-term investors can look past the near-term volatility to bet on the potential for a fundamental recovery and valuation re-rating of its enduring brands.